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ABSTRACT
Objective: The objectives of the present study were to evaluate the activity of phospholipase A2, plasma elastase enzymes and to assess relation with 
an inflammatory marker high sensitive C-reactive protein (hs-CRP) in nonpregnant before and after delivery of normotensive pregnant and pre-
eclamptic women.
Methods: The study population consists of three groups: Nonpregnant (Group 1, n=57), normotensive pregnant (Group 2, n=57), and pre-eclamptic 
women (Group 3, n=57). Groups 2 and 3 were followed after delivery within 48 hrs. Phospholipase A2, plasma elastase, and hs-CRP levels were 
determined spectrophotometrically.
Results: The plasma elastase, phospholipase A2 activity, and hs-CRP were elevated in pre-eclampsia significantly (p<0.05), nonsignificant rise in 
normotensive pregnant before delivery condition compared to nonpregnant women. However, plasma elastase in normal pregnancy and pre-eclampsia 
were decreased by 1.2- and 2.07-fold, respectively, after delivery. Whereas phospholipase A2 and hs-CRP found to be nonsignificantly decreased in the 
postdelivery status of the both the groups. Receiver operating characteristics curve analysis showed that elastase enzyme has diagnostic importance 
to assess inflammation on the basis of area under curve (0.758).
Conclusion: Our research findings generated knowledge about raised level of plasma elastase enzyme by neutrophil degranulation represents 
inflammation in pre-eclampsia. Elevated elastase, phospholipase A2 with hs-CRP in pre-eclampsia serves as indicators of inflammation.
Keywords: Elastase, High sensitive C - reactive protein, Phospholipase A2, Pre-eclampsia.
INTRODUCTION
Pre-eclampsia is a multisystem obstetric problem associated with 
hypertension, proteinuria, and edema after 20 weeks of pregnancy [1]. 
The symptoms are persistent headache, blurred vision, vomiting, 
and abdominal pain [2]. The pre-eclampsia complications may result 
in fetal uterine growth restriction, preterm delivery, maternal and 
fetal morbidity and mortality [3,4]. Research reports are available on 
inflammatory response [5], leukocyte activation [6], dyslipidemia [7], 
oxidative stress, and intrauterine hypoxia [8] as a potential cause for 
generation of free radicals and inflammatory mediators.
Neutrophil elastase gene located on chromosome 19 at p13.3. Protein 
expressed is a serine protease (EC No. 3.4.21.37) consisting of 218 amino 
acid residues with a molecular weight 29.5 kDa. It exerts biological role 
in the degradation of collagen IV and elastin in causing inflammation [9]. 
Phospholipase A2 gene located on chromosome number 1 at q31.1. 
The expressed protein is heat stable, calcium-dependent enzyme (EC 
No. 3.1.1.4) with molecular weight 85 kDa. Phospholipase A2 enzyme 
cleaves arachidonic acid at Sn2 position in phospholipid; the released 
product serves as precursor for leukotriene’s synthesis which acts as 
inflammatory mediators [10].
High sensitive C-reactive protein (hs-CRP) is a plasma globulin fraction 
synthesized in the liver during acute inflammation phase in response 
to pneumococci infection where it binds to carbohydrate moiety of the 
capsule of bacteria. Circulating level of CRP in the range of 0.5-10 mg/L 
considered as hs-CRP, whereas the concentration in the range of 
10-1000 mg/L is a nonspecific indicator of inflammation [11].
In our earlier research reports, we presented increased concentration 
of oxidative stress and decreased total antioxidant status [12] and also 
increased xanthine oxidase activity with the inverse relation of nitric 
oxide in pre-eclampsia [13,14]. There is seldom information available 
with respect to phospholipase A2 and plasma elastase in pre-eclampsia. 
Therefore, in the present study, an attempt was made to estimate the 
phospholipase A2 and plasma elastase activities in comparison with 
hs-CRP to assess inflammation in pre-eclampsia and normotensive 
pregnant women. These parameters were also measured in both the 
groups after delivery within 48 hrs made the study distinct.
METHODS
The study was conducted between December 2014 and May 2016 by 
the Department of Biochemistry in collaboration with the Department 
of Obstetrics and Gynecology, R. L. Jalappa Hospital and Research 
Center, Kolar, Karnataka, India. It was conducted after obtaining the 
Institutional Ethics Committee approval from Sri Devaraj Urs Medical 
College. The participants of the study population were enrolled after 
obtaining individual patient written informed consent.
The study population was allocated into three groups. Group 1, 
nonpregnant (n=57); Group 2, normotensive pregnant (n=57); Group 3 
pre-eclamptic women (n=57). G2 and G3 were in 30-39 weeks of 
gestation before delivery and were followed after delivery within 48 
hrs. G2 and G3 subjects were clinically diagnosed from obstetrics and 
gynecology. The age-matched control populations (G1) were randomly 
recruited from the healthy volunteers of the Sri Devaraj Urs Medical 
College and were in age group of 20-30 years.
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Pre-eclampsia was diagnosed with blood pressure ≥140/90 mm Hg, 
proteinuria ≥300 mg/24 hrs after 20 weeks of gestation, were included 
as per national high blood pressure education program working 
group. The subjects with any history of renal disease, thyroid disorder, 
chronic hypertension, gestational diabetes, epilepsy, hypertensive 
encephalopathy, and cardiovascular disease were excluded from the 
study.
About 4 ml of blood sample was collected from each subject under the 
study groups using appropriate vacutainer under aseptic conditions to 
obtain serum and plasma. These samples were stored at −80°C until 
further analysis.
Fine chemicals such as N-Succinyl-ala-ala-ala-p-Nitroanilide (SAAANA), 
leukocyte elastase, phospholipid, and phospholipase A2 were obtained 
from Sigma-Aldrich, USA. hs-CRP immunoturbidimetric kit was 
commercially obtained from Euro-Diagnostic System, Chennai, India. 
All other chemicals and reagents used were of analytical grade.
Elastase hydrolyses synthetic substrate SAAANA to give rise to 
products N-Succinyl-ala-ala-ala and p-nitroanilide. The absorbance 
of p-nitroanilide was measured in a spectrophotometer at 410 nm 
wavelength [15].
The CRP-ultrasensitive is a quantitative turbidimetric test for the 
measurement of low levels of CRP in human serum or plasma. Latex 
particles coated with specific antihuman CRP are agglutinated when 
mixed with samples containing CRP. The agglutination causes an 
absorbance change, dependent on the CRP contents of the patient 
sample that can be quantified by comparison from a calibrator of 
known CRP concentration.
Phospholipase A2 hydrolyzes the Sn2-fatty-acyl ester bond of phosphor-
glyceride liberating free fatty acid and lysophospholipid. Based on 
the absorbance change of bromothymol blue, indicators with the 
concentration of hydrogen ion released from enzyme catalyzed reaction 
were measured at 620 nm [16].
The results were tabulated as mean±standard deviation (SD) and 
analyzed using one-way ANOVA test with post-hoc-Dunnett analysis to 
compare the values between the three groups. Paired t-test was used 
to compare the changes before and after delivery in normal pregnancy 
and pre-eclampsia. A probability value of p<0.05 was considered as 
statistically significant. Receiver operating characteristics (ROC) curve 
was plotted to find out the diagnostic importance of the parameters 
measured under study. Statistical analysis was performed with licensed 
version of SPSS 20.
RESULTS
Table 1 depicted the mean±SD of the elastase, phospholipase A2, 
and hs-CRP as an inflammatory indicator. Considerable increase in 
elastase (5.8 U/ml±3.01), phospholipase A2 (70.7 U/ml±18.4), and 
hs-CRP (8.6 mg/L±14.1) in normal pregnancy when compared to 
nonpregnant and further increase of these parameters (26.85±79.31, 
79.02±27.6, 11.5±14.2), respectively, in pre-eclampsia when 
compared to normal pregnancy. Analysis of the results showed 
that the marked rise in the elastase, phospholipase A2 activity 
in pre-eclampsia noticed when compared with the well-known 
inflammatory marker hs-CRP. In pre-eclampsia, there was 6.7-fold 
increase of elastase enzyme and 4.0-fold increase of hs-CRP observed 
when compared to nonpregnant women.
Table 2 shows the comparison of study parameters among nonpregnant, 
normotensive pregnant, and pre-eclampsia. Phospholipase A2 and 
elastase were significantly increased (p<0.05) in pre-eclampsia, and 
the same parameters were statistically nonsignificant in normotensive 
pregnant when compared to nonpregnant women. Whereas hs-
CRP level significantly increased in normal pregnancy (p<0.05) and 
pre-eclampsia (p<0.001) when compared with that of nonpregnant.
Table 3 depicts the elastase, phospholipase A2, and hs-CRP levels 
during pre- and post-delivery of normal pregnant and pre-eclampsia 
cases. These parameters were increased in pre-eclampsia prominently 
compared to normal pregnant during predelivery. However, elastase 
activity decreased by 1.2 and 2.07-fold, respectively, in normal pregnancy 
and pre-eclampsia during after delivery, whereas phospholipase A2 and 
hs-CRP were found to be nonsignificantly decreased (p>0.05) during 
postdelivery.
Table 4 illustrates the ROC curve features such as sensitivity, specificity, 
and area under curve for hs-CRP, phospholipase A2, and plasma elastase 
in pre-eclampsia. ROC analysis showed that plasma elastase had area 
under the curve of 0.758. Phospholipase A2 did not show any appreciable 
diagnostic importance. Figs. 1-3 shows the levels of phospholipase A2, 
plasma elastase, and hs-CRP in nonpregnant before and after delivery 
of normal pregnant and pre-eclamptic cases.
DISCUSSION
Pre-eclampsia is a multifactorial pregnancy disorder involving various 
types of system attributing to the pathophysiology of placenta. 
Feto-maternal immune reactions in the 1st week of pregnancy, impaired 
arterial invasion by trophoblast, and transformation of spiral arteries 
followed by altered placental perfusion. It results in chronic hypoxia 
Table 1: Comparison of the biochemical parameters between 
groups in the study population
Parameters Mean±SD
G1 (n=57) G2 (n=57) G3 (n=57)




hs-CRP (mg/l) 2.9±1.54 8.6±14.1 11.5±14.2
G1: Nonpregnant, G2: Normotensive pregnant, G3: Pre-eclampsia, SD: Standard 
deviation, hs-CRP: High sensitive C-reactive protein
Table 2: Comparisons of biochemical parameters showing 
significance between groups in study population by 
post-hoc‑Dunnett multiple comparisons
Parameters G1 versus G2 G1 versus G3
Elastase (U/ml) NS <0.05*
Phospholipase A2 (U/ml) NS <0.05*
hs-CRP (mg/l) <0.05* <0.001**
G1: Nonpregnant, G2: Normotensive pregnant, G3: Pre-eclampsia. *Statistically 
significant, **Highly significant, NS: Nonsignificant, hs-CRP: High sensitive 
C-reactive protein
Fig. 1: It shows the phospholipase A2 activity in nonpregnant 
before and after delivery of normal pregnant and 
pre‑eclamptic women
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that triggers intensity of oxidative stress that has an impact on 
placental syncytiotrophoblast cell apoptosis and necrosis [17]. The 
rate of formation of placental debris has pro-inflammatory substances, 
angiogenic, and antiangiogenic factors, etc., which lead to endothelial 
dysfunction and systemic inflammatory response, thus placenta play a 
central role in inflammatory process [18].
An inflammatory response in pre-eclampsia is usually accompanied by 
increased concentration of pro-inflammatory signaling molecules such 
as cytokines, activated neutrophils, and positive acute phase plasma 
proteins. Neutrophil activation may occur in the presence of cytokines 
such as tumor necrosis factor-α during an inflammatory process. 
Degranulation of neutrophils releases elastase enzyme that prolongs 
the inflammation by modification of pro-inflammatory cytokines 
and degrading proteins involved in the inflammation. In addition to 
this, myeloperoxidase also present in neutrophil granules increases 
oxidative stress by the additional production of hydroxyl radical and 
hypochlorous acid [19]. Hence, neutrophil activation results in vascular 
damage and dysfunction. Therefore, plasma elastase can be used to 
assess in vivo neutrophil activation. CRP is increased rapidly in response 
to inflammatory stimuli along with elastase in pre-eclampsia [20]. 
So that, increased elastase in plasma serves as a predictive marker of 
pregnancy induced inflammation [21].
A systemic inflammatory response involves leukocyte activation by 
elastase, acute phase response by hs-CRP, and metabolic features of 
systemic inflammation by phospholipase A2 were presented in the 
current study. Elastase and phospholipase A2 activity were compared 
with reliable inflammatory marker hs-CRP. In our study, these 
biochemical parameters were elevated in normal pregnancy and 
further accentuated in pre-eclampsia.
We observed the systemic inflammatory response in pre-eclampsia 
through hs-CRP which is similar to the research reports of 
von Versen-Hoeynck 2009 [22], Belo 2009 [23]. The increase in plasma 
elastase in early onset of pre-eclampsia has been reported by Gupta 
2006 [24]. Elastase released from polymorphonuclear lymphocytes 
during inflammatory condition; hence, the plasma levels were increased 
considerably [25]. Therefore, in the current study, plasma elastase was 
compared with the hs-CRP.
Phospholipase A2 by virtue of hydrolysis of phospholipid releases 
arachidonic acid that serves as precursor for the synthesis of eicosanoids 
which participates in the inflammatory process. Phospholipase A2 
enzyme activity was measured to know whether this enzyme can be 
included under inflammatory marker for consideration. Statistical 
significance of phospholipase A2 activity was seen in nonpregnant and 
pre-eclampsia cases.
Even though, the importance of phospholipase A2 in pre-eclampsia 
found to be contradictory [26-28], but our results highlighted increased 
phospholipase A2 activity in pre-eclampsia compared to nonpregnant 
women. However, phospholipase A2 did not show diagnostic 
importance as per ROC analysis. Limitation of the study confines to the 
determination of plasma elastase, phospholipase A2, and hs-CRP from 
the time of pregnancy to all trimesters to denote the number of chances 
of pregnancy translated into pre-eclampsia.
CONCLUSION
Our research findings generated a new knowledge about plasma elastase 
and phospholipase A2 increase in normal pregnancy and further rise 
in pre-eclampsia. Elevation of these enzymes evidences inflammation 
Table 3: Elastase, phospholipase A2, and hs‑CRP parameters during before and after delivery in normotensive pregnant and 
pre‑eclamptic women
Parameters Mean±SD
Normotensive pregnant (n=57) Pre‑eclampsia (n=57)
Predelivery Postdelivery p Predelivery Postdelivery p
Elastase (U/ml) 5.80±3.019 4.6±1.64 <0.05* 26.85±79.30 12.91±7.72 >0.05
Phospholipase A2 (U/ml) 70.72±18.43 70.03±14.66 >0.05 79.01±27.55 73.30±25.72 >0.05
hs-CRP (mg/L) 8.6±14.15 6.6±15.2 >0.05 11.5±14.24 10.3±20.4 >0.05
*Statistically significant. SD: Standard deviation, hs-CRP: High sensitive C-reactive protein






hs-CRP 57.1 73.7 0.708 0.615-0.790
Phospholipase A2 35.7 86 0.580 0.484-0.672
Plasma elastase 74.3 86 0.758 0.669-0.834
AUC: Area under curve, hs-CRP: High sensitive C-reactive protein, CI: Confidence 
interval, ROC: Receiver operating characteristics
Fig. 2: It Illustrates the plasma elastase activity in 
nonpregnant before and after delivery of normal pregnant and 
pre‑eclamptic cases
Fig. 3: It presents the high sensitive C‑reactive protein levels in 
nonpregnant before and after delivery of normal pregnant and 
pre‑eclamptic cases
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in pre-eclampsia when tested along with hs-CRP. Phospholipase A2 
activity increased but did not show diagnostic importance, whereas 
plasma elastase can be considered for diagnostic utility. Elevated 
elastase activity represents enhanced maternal inflammatory process 
by neutrophil activation and degranulation in pre-eclampsia.
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